Skip to content

Opinion

PhRMA: What’s ahead for biopharmaceuticals in 2013?

It’s human nature to look ahead to the New Year. What will 2013 hold for America’s biopharmaceutical research sector? Well, quite a bit. John Castellani We will join other stakeholders in the dialogue over the role of health care costs in our nation’s economic challenges.

The most innovative retailer in America

If you’re within a thousand miles of Chicago, make the journey to the Windy City and drop in on the new, 30,000-square-foot (25,000-square-foot selling) Walgreens drug store in the city’s Bucktown/Wicker Park neighborhood.

Drug chains should cater to care-at-home needs

from clinical to retail settings. So, who is, or will be, shopping your home health care department? Have you been reacting to your customers’ needs or anticipating them? The number of seniors in the United States is rising

New approaches to health care long overdue

The walls that have demarcated areas of responsibility within the U.S. health care system are beginning to crumble, as payers, providers and patients seek better ways to ensure quality care and, at the same time, limit expenditures that are the highest in the world, consuming almost 18% of GDP.

Visitors gain better grasp of Alliance Boots

A small group of American suppliers journeyed to England earlier this month to learn about Alliance Boots, meet with that company’s senior managers, and attempt to gain a clearer understanding of some of the ways the Alliance Boots merger with Walgreens will influence the future of mass retailing in

CVS, Walgreens battle over Rx customers

In the aftermath of the agreement between Walgreens and Express Scripts wherein the nation’s largest drug chain will once again honor prescriptions from Express Scripts members, a competitive battle has emerged between Walgreens and CVS, its No. 1 rival.

Rx determined to shape its own destiny

In his speech during one of the business sessions at the recent National Association of Chain Drug Stores Pharmacy and Technology Conference in Denver, Steve Anderson, NACDS’ president and chief executive officer, talked about the profession’s newfound assertiveness.